IR-TMS for Alcohol Use Disorder
This study is testing a new treatment called Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for people with Alcohol Use Disorder (AUD). IR-TMS uses magnetic fields to target specific parts of the brain. You might be able to join if you are 18-65 years old, have a diagnosis of moderate to severe AUD, and meet certain drinking criteria, including a specific blood test result (PEth >20 ng/mL). The study aims to see if IR-TMS can help reduce the amount you drink. Success will be measured by changes in your PEth level at 1 and 6 months after starting the study. The study plans to enroll 150 participants.
- Study design
- This interventional study plans to enroll 150 participants with Alcohol Use Disorder. Participants will be randomly assigned to one of three treatment groups, each targeting a different brain area.
- What's involved
- You would receive up to 4 IR-TMS treatments per day for up to 10 days, have brain scans (MRI), provide blood and urine samples, and answer questions about your drinking and mental health.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your PEth level will be measured at 1 month and 6 months after the start of the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Image-guided, Robot Navigated Transcranial Magnetic Stimulation (IR-TMS) for Alcohol Use Disorder (AUD)
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Brett C Ginsburg, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center at San Antonio
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Measure of Phosphatidylethanol (PEth) levelBaseline, 1 month and 6 months
Determine if accelerated IR-TMS significantly changes alcohol consumption (as measured by phosphatidylethanol (PEth)) in participants with AUD.